LEXARIA BIOSCIENCE CORP. Inventory Write-down
LEXARIA BIOSCIENCE CORP. (LEXX) reported Inventory Write-down of $213.82 thousand for the 12-month period ending 2025-08-31, per its 10-K filed 2025-11-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2025-11-28
- LEXARIA BIOSCIENCE CORP. inventory write-down for the quarter ending 2023-08-31 was $0.00.
- LEXARIA BIOSCIENCE CORP. inventory write-down for the quarter ending 2023-05-31 was $9.03K.
- LEXARIA BIOSCIENCE CORP. inventory write-down for the quarter ending 2023-02-28 was $4.15K, a 83.57% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. inventory write-down for the quarter ending 2022-11-30 was $25.24K.
- LEXARIA BIOSCIENCE CORP. inventory write-down for fiscal 2025 was $213.82K.
- LEXARIA BIOSCIENCE CORP. inventory write-down for fiscal 2023 was $38.42K.
- LEXARIA BIOSCIENCE CORP. inventory write-down for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- LEXARIA BIOSCIENCE CORP. inventory write-down for fiscal 2021 was $2.48K, a 69.88% decline from fiscal 2020.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 6 month as first filed | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|---|
| 2025-08-31 | $213.82K 10-K · filed 2025-11-28 | ||||
| 2023-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-20 | $9.03K derived: sum of 2 quarters · filed 2023-11-20 | $13.18K derived: sum of 3 quarters · filed 2023-11-20 | $38.42K 10-K · filed 2023-11-20 | |
| 2023-05-31 | $9.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-07-14 | $13.18K derived: sum of 2 quarters · filed 2023-07-14 | $38.42K 10-Q · filed 2023-07-14 | $38.42K derived: sum of 4 quarters · filed 2023-07-14 | |
| 2023-02-28 | $4.15K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-04-14 | $29.39K 10-Q · filed 2023-04-14 | $29.39K derived: sum of 3 quarters · filed 2023-04-14 | $4.15K derived: sum of 4 quarters · filed 2023-04-14 | |
| 2022-11-30 | $25.24K 10-Q/A · filed 2023-01-18 | $25.24K derived: sum of 2 quarters · filed 2023-01-18 | $0.00 derived: sum of 3 quarters · filed 2023-01-18 | $25.24K derived: sum of 4 quarters · filed 2023-04-14 | |
| 2022-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | -$25.24K derived: sum of 2 quarters · filed 2022-11-28 | $0.00 derived: sum of 3 quarters · filed 2023-04-14 | $0.00 10-K · filed 2022-11-28 | |
| 2022-05-31 | -$25.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-07-14 | $0.00 derived: sum of 2 quarters · filed 2023-04-14 | $0.00 10-Q · filed 2022-07-14 | $0.00 derived: sum of 4 quarters · filed 2023-04-14 | |
| 2022-02-28 | $25.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-04-14 | $25.24K 10-Q · filed 2023-04-14 | $0.00 10-Q · filed 2022-04-11 | $25.24K derived: sum of 3 quarters · filed 2023-04-14 | $25.24K derived: sum of 4 quarters · filed 2023-04-14 |
| 2021-11-30 | $0.00 10-Q · filed 2022-01-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-28 | $0.00 derived: sum of 3 quarters · filed 2022-11-28 | $717.00 derived: sum of 4 quarters · filed 2022-11-28 | |
| 2021-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | $0.00 derived: sum of 2 quarters · filed 2022-11-28 | $717.00 derived: sum of 3 quarters · filed 2022-11-28 | $2.48K 10-K · filed 2022-11-28 | |
| 2021-05-31 | $0.00 10-Q · filed 2021-07-15 | $717.00 derived: sum of 2 quarters · filed 2021-07-15 | $2.48K 10-Q · filed 2022-07-14 | $2.48K derived: sum of 4 quarters · filed 2022-01-14 | |
| 2021-02-28 | $717.00 10-Q · filed 2021-04-14 | $2.48K 10-Q · filed 2022-04-11 | $2.48K derived: sum of 3 quarters · filed 2022-01-14 | $10.72K derived: sum of 4 quarters · filed 2022-01-14 | |
| 2020-11-30 | $1.76K 10-Q · filed 2022-01-14 | $1.76K derived: sum of 2 quarters · filed 2022-01-14 | $10.01K derived: sum of 3 quarters · filed 2022-01-14 | $10.01K derived: sum of 4 quarters · filed 2022-01-14 | |
| 2020-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-29 | $8.24K derived: sum of 2 quarters · filed 2021-11-29 | $8.24K derived: sum of 3 quarters · filed 2021-11-29 | $8.24K 10-K · filed 2021-11-29 | |
| 2020-05-31 | $8.24K 10-Q · filed 2021-07-15 | $8.24K derived: sum of 2 quarters · filed 2021-07-15 | $8.24K 10-Q · filed 2021-07-15 | ||
| 2020-02-29 | $0.00 10-Q · filed 2021-04-14 | $0.00 10-Q · filed 2021-04-14 | |||
| 2019-11-30 | $7.18K 10-Q · filed 2020-01-09 | ||||
| 2019-08-31 | $7.18K 10-K · filed 2020-10-15 | ||||
| 2018-08-31 | $357.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-14 | $3.98K derived: sum of 2 quarters · filed 2019-11-14 | $9.42K derived: sum of 3 quarters · filed 2019-11-14 | $12.97K 10-K · filed 2019-11-14 | |
| 2018-05-31 | $3.63K 10-Q · filed 2019-07-08 | $9.06K derived: sum of 2 quarters · filed 2019-07-08 | $12.61K 10-Q · filed 2019-07-08 | $76.57K derived: sum of 4 quarters · filed 2019-07-08 | |
| 2018-02-28 | $5.44K 10-Q · filed 2019-04-15 | $8.98K 10-Q · filed 2019-04-15 | $72.94K derived: sum of 3 quarters · filed 2019-04-15 | $73.67K derived: sum of 4 quarters · filed 2019-04-15 | |
| 2017-11-30 | $3.55K 10-Q · filed 2019-01-11 | $67.51K derived: sum of 2 quarters · filed 2019-01-11 | $68.23K derived: sum of 3 quarters · filed 2019-01-11 | $68.73K derived: sum of 4 quarters · filed 2019-01-11 | |
| 2017-08-31 | $63.96K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | $64.69K derived: sum of 2 quarters · filed 2018-11-14 | $65.19K derived: sum of 3 quarters · filed 2018-11-14 | $68.61K 10-K · filed 2018-11-14 | |
| 2017-05-31 | $726.00 10-Q · filed 2018-07-13 | $1.23K derived: sum of 2 quarters · filed 2018-07-13 | $4.65K 10-Q · filed 2018-07-13 | $14.45K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-02-28 | $501.00 10-Q · filed 2018-04-12 | $3.92K 10-Q · filed 2018-04-12 | $13.72K derived: sum of 3 quarters · filed 2018-11-14 | $13.72K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2016-11-30 | $3.42K 10-Q · filed 2018-01-12 | $13.22K derived: sum of 2 quarters · filed 2018-11-14 | $13.22K derived: sum of 3 quarters · filed 2018-11-14 | $36.00K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2016-08-31 | $9.79K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | $9.79K derived: sum of 2 quarters · filed 2018-11-14 | $32.58K derived: sum of 3 quarters · filed 2018-11-14 | $44.04K 10-K · filed 2018-11-14 | |
| 2016-05-31 | $0.00 10-Q · filed 2017-07-14 | $22.78K derived: sum of 2 quarters · filed 2017-07-14 | $34.25K 10-Q · filed 2017-07-14 | $34.25K derived: sum of 4 quarters · filed 2017-07-14 | |
| 2016-02-29 | $22.78K 10-Q · filed 2017-04-14 | $34.25K 10-Q · filed 2017-04-14 | $34.25K derived: sum of 3 quarters · filed 2017-04-14 | $34.25K derived: sum of 4 quarters · filed 2017-04-14 | |
| 2015-11-30 | $11.46K 10-Q · filed 2017-01-13 | $11.46K derived: sum of 2 quarters · filed 2017-01-13 | $11.46K derived: sum of 3 quarters · filed 2017-01-13 | ||
| 2015-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-29 | $0.00 derived: sum of 2 quarters · filed 2016-11-29 | $0.00 10-K · filed 2016-11-29 | ||
| 2015-05-31 | $0.00 10-Q · filed 2016-07-13 | $0.00 10-Q · filed 2016-07-13 | |||
| 2014-11-30 | $0.00 10-Q · filed 2016-01-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |